世界の自己免疫疾患治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Autoimmune Disease Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0520 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、自己免疫疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤、その他）、用途別市場規模（病院、クリニック、独立型薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・自己免疫疾患治療の市場動向 ・企業の競争状況、市場シェア ・自己免疫疾患治療の種類別市場規模（免疫抑制剤、抗炎症薬、コルチコステロイド、非ステロイド性抗炎症薬、生物製剤、その他） ・自己免疫疾患治療の用途別市場規模（病院、クリニック、独立型薬局、その他） ・自己免疫疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・自己免疫疾患治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・自己免疫疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・自己免疫疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・自己免疫疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Novartis、Johnson & Johnson Services、Merck、Sanofi、Abott、Bristol-Myers Squibb、Amgen、Bayer、F. Hoffmann-La Roche、Eli Lilly and Company） ・結論

Market Analysis and Insights: Global Autoimmune Disease Therapeutics Market
The global Autoimmune Disease Therapeutics market size is projected to reach US$ 116550 million by 2026, from US$ 98660 million in 2019, at a CAGR of 2.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Disease Therapeutics market.

Global Autoimmune Disease Therapeutics Scope and Market Size
Autoimmune Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunosuppressants
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Other

Segment by Application
Hospitals
Clinics
Independent Pharmacies
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Novartis
Johnson & Johnson Services
Merck
Sanofi
Abott
Bristol-Myers Squibb
Amgen
Bayer

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunosuppressants
1.2.3 Anti-Inflammatory Drugs
1.2.4 Corticosteroids
1.2.5 Nonsteroidal Anti-inflammatory Drugs
1.2.6 Biologics
1.2.7 Other
1.3 Market by Application
1.3.1 Global Autoimmune Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Independent Pharmacies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Autoimmune Disease Therapeutics Market Perspective (2016-2027)
2.2 Autoimmune Disease Therapeutics Growth Trends by Regions
2.2.1 Autoimmune Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autoimmune Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Autoimmune Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Autoimmune Disease Therapeutics Industry Dynamic
2.3.1 Autoimmune Disease Therapeutics Market Trends
2.3.2 Autoimmune Disease Therapeutics Market Drivers
2.3.3 Autoimmune Disease Therapeutics Market Challenges
2.3.4 Autoimmune Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Therapeutics Players by Revenue
3.1.1 Global Top Autoimmune Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Autoimmune Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Autoimmune Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Therapeutics Revenue
3.4 Global Autoimmune Disease Therapeutics Market Concentration Ratio
3.4.1 Global Autoimmune Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Therapeutics Revenue in 2020
3.5 Autoimmune Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Autoimmune Disease Therapeutics Breakdown Data by Type
4.1 Global Autoimmune Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2022-2027)

5 Autoimmune Disease Therapeutics Breakdown Data by Application
5.1 Global Autoimmune Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Autoimmune Disease Therapeutics Market Size (2016-2027)
6.2 North America Autoimmune Disease Therapeutics Market Size by Type
6.2.1 North America Autoimmune Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Autoimmune Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Autoimmune Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Autoimmune Disease Therapeutics Market Size by Application
6.3.1 North America Autoimmune Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Autoimmune Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Autoimmune Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Autoimmune Disease Therapeutics Market Size by Country
6.4.1 North America Autoimmune Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Autoimmune Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Autoimmune Disease Therapeutics Market Size (2016-2027)
7.2 Europe Autoimmune Disease Therapeutics Market Size by Type
7.2.1 Europe Autoimmune Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Autoimmune Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Autoimmune Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Autoimmune Disease Therapeutics Market Size by Application
7.3.1 Europe Autoimmune Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Autoimmune Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Autoimmune Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Autoimmune Disease Therapeutics Market Size by Country
7.4.1 Europe Autoimmune Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Autoimmune Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Autoimmune Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Autoimmune Disease Therapeutics Market Size by Type
9.2.1 Latin America Autoimmune Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Autoimmune Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Autoimmune Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Autoimmune Disease Therapeutics Market Size by Application
9.3.1 Latin America Autoimmune Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Autoimmune Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Autoimmune Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Autoimmune Disease Therapeutics Market Size by Country
9.4.1 Latin America Autoimmune Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Autoimmune Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Autoimmune Disease Therapeutics Introduction
11.1.4 Pfizer Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Autoimmune Disease Therapeutics Introduction
11.2.4 Novartis Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Johnson & Johnson Services
11.3.1 Johnson & Johnson Services Company Details
11.3.2 Johnson & Johnson Services Business Overview
11.3.3 Johnson & Johnson Services Autoimmune Disease Therapeutics Introduction
11.3.4 Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.3.5 Johnson & Johnson Services Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Autoimmune Disease Therapeutics Introduction
11.4.4 Merck Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Autoimmune Disease Therapeutics Introduction
11.5.4 Sanofi Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Abott
11.6.1 Abott Company Details
11.6.2 Abott Business Overview
11.6.3 Abott Autoimmune Disease Therapeutics Introduction
11.6.4 Abott Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.6.5 Abott Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Autoimmune Disease Therapeutics Introduction
11.7.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Autoimmune Disease Therapeutics Introduction
11.8.4 Amgen Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Autoimmune Disease Therapeutics Introduction
11.9.4 Bayer Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 F. Hoffmann-La Roche
11.10.1 F. Hoffmann-La Roche Company Details
11.10.2 F. Hoffmann-La Roche Business Overview
11.10.3 F. Hoffmann-La Roche Autoimmune Disease Therapeutics Introduction
11.10.4 F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.10.5 F. Hoffmann-La Roche Recent Development
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Details
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Autoimmune Disease Therapeutics Introduction
11.11.4 Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2016-2021)
11.11.5 Eli Lilly and Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Autoimmune Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunosuppressants
Table 3. Key Players of Anti-Inflammatory Drugs
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Nonsteroidal Anti-inflammatory Drugs
Table 6. Key Players of Biologics
Table 7. Key Players of Other
Table 8. Global Autoimmune Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Autoimmune Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Autoimmune Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Autoimmune Disease Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Autoimmune Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Autoimmune Disease Therapeutics Market Share by Regions (2022-2027)
Table 14. Autoimmune Disease Therapeutics Market Trends
Table 15. Autoimmune Disease Therapeutics Market Drivers
Table 16. Autoimmune Disease Therapeutics Market Challenges
Table 17. Autoimmune Disease Therapeutics Market Restraints
Table 18. Global Autoimmune Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Autoimmune Disease Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Therapeutics as of 2020)
Table 21. Ranking of Global Top Autoimmune Disease Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Autoimmune Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Autoimmune Disease Therapeutics Product Solution and Service
Table 25. Date of Enter into Autoimmune Disease Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Autoimmune Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Autoimmune Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Autoimmune Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Autoimmune Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Autoimmune Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Autoimmune Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Autoimmune Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Autoimmune Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Autoimmune Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Autoimmune Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Autoimmune Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Autoimmune Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Autoimmune Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Autoimmune Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Autoimmune Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Autoimmune Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Autoimmune Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Autoimmune Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Autoimmune Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Autoimmune Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Autoimmune Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Autoimmune Disease Therapeutics Product
Table 68. Pfizer Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Autoimmune Disease Therapeutics Product
Table 73. Novartis Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Novartis Recent Development
Table 75. Johnson & Johnson Services Company Details
Table 76. Johnson & Johnson Services Business Overview
Table 77. Johnson & Johnson Services Autoimmune Disease Therapeutics Product
Table 78. Johnson & Johnson Services Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Johnson & Johnson Services Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Autoimmune Disease Therapeutics Product
Table 83. Merck Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Autoimmune Disease Therapeutics Product
Table 88. Sanofi Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Sanofi Recent Development
Table 90. Abott Company Details
Table 91. Abott Business Overview
Table 92. Abott Autoimmune Disease Therapeutics Product
Table 93. Abott Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Abott Recent Development
Table 95. Bristol-Myers Squibb Company Details
Table 96. Bristol-Myers Squibb Business Overview
Table 97. Bristol-Myers Squibb Autoimmune Disease Therapeutics Product
Table 98. Bristol-Myers Squibb Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Bristol-Myers Squibb Recent Development
Table 100. Amgen Company Details
Table 101. Amgen Business Overview
Table 102. Amgen Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Amgen Recent Development
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Autoimmune Disease Therapeutics Product
Table 107. Bayer Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 108. Bayer Recent Development
Table 109. F. Hoffmann-La Roche Company Details
Table 110. F. Hoffmann-La Roche Business Overview
Table 111. F. Hoffmann-La Roche Autoimmune Disease Therapeutics Product
Table 112. F. Hoffmann-La Roche Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 113. F. Hoffmann-La Roche Recent Development
Table 114. Eli Lilly and Company Company Details
Table 115. Eli Lilly and Company Business Overview
Table 116. Eli Lilly and Company Autoimmune Disease Therapeutics Product
Table 117. Eli Lilly and Company Revenue in Autoimmune Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 118. Eli Lilly and Company Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Immunosuppressants Features
Figure 3. Anti-Inflammatory Drugs Features
Figure 4. Corticosteroids Features
Figure 5. Nonsteroidal Anti-inflammatory Drugs Features
Figure 6. Biologics Features
Figure 7. Other Features
Figure 8. Global Autoimmune Disease Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Independent Pharmacies Case Studies
Figure 12. Other Case Studies
Figure 13. Autoimmune Disease Therapeutics Report Years Considered
Figure 14. Global Autoimmune Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Autoimmune Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Autoimmune Disease Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Autoimmune Disease Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Autoimmune Disease Therapeutics Market Share by Players in 2020
Figure 19. Global Top Autoimmune Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Autoimmune Disease Therapeutics Revenue in 2020
Figure 21. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Autoimmune Disease Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Autoimmune Disease Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Autoimmune Disease Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Autoimmune Disease Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Autoimmune Disease Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Autoimmune Disease Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Autoimmune Disease Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Autoimmune Disease Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Autoimmune Disease Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Autoimmune Disease Therapeutics Market Share by Region (2016-2027)
Figure 43. China Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Autoimmune Disease Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Autoimmune Disease Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Autoimmune Disease Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Autoimmune Disease Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Autoimmune Disease Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Autoimmune Disease Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Autoimmune Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Pfizer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 64. Johnson & Johnson Services Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 67. Abott Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 69. Amgen Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 70. Bayer Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 71. F. Hoffmann-La Roche Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 72. Eli Lilly and Company Revenue Growth Rate in Autoimmune Disease Therapeutics Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---